A mother is seeking financial assistance to cover the £14,000 cost of potentially life-saving treatment for her two-year-old son, who has a rare medical condition not seen elsewhere in the world. Mel Morris faced a sudden crisis on July 31 when her youngest child, Oli-Jay, experienced seizures just two weeks after his second birthday.
Following the emergency, Oli-Jay received intensive medical care at Addenbrooke’s Hospital in Cambridge, including various medications and tests. Doctors diagnosed him with a unique De Novo DNM1L gene mutation, resulting in a form of mitochondrial disease that impairs his body’s energy production, affecting basic functions like eating and breathing.
Despite ongoing care at home in Haverhill, Suffolk, with round-the-clock support from his family, Oli-Jay’s condition remains challenging due to its rarity. Seeking further treatment options, his father contacted the DNM1L Foundation in the United States, which connected them with Unravel Biosciences for a specialized genetic analysis, potentially offering medications not available through the NHS.
The family hopes to raise the necessary funds for this critical analysis, which could significantly enhance Oli-Jay’s quality of life. Mel emphasizes the urgency of the situation, highlighting that time is of the essence in securing the treatment that could make a difference for her son. To support their fundraising efforts and contribute to Oli-Jay’s journey, donations can be made at the fundraising page.
Mel Morris expressed the immense strain the situation has placed on her family, underscoring the vital importance of the fundraising campaign in securing the treatment necessary to save Oli-Jay’s life. This initiative stems from a place of hope and determination to provide a better future for Oli-Jay and other families affected by similar conditions.
The family remains resilient despite past hardships, including the loss of Mel’s nephew to a rare brain tumor in 2019. As they navigate this challenging journey, they are grateful for any support towards Oli-Jay’s treatment.